GlassScriptPhysician profile
Daniel Mark Frendl
NPI 1003290867
$14,827.12
in general payments reported to CMS, 2019-2025
7 companies · $11K in 2025
The $11K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $496 · 2023: $1,781 · 2024: $1,649 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,000 · Food and Beverage: $2,184 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,663 · Travel and Lodging: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,000.00 |
| Food and Beverage | $2,183.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,662.50 |
| Travel and Lodging | $1,485.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,710.48 | 2022-2025 | General - Oncology, Spaceoar System, General - Therapies |
| Bk Medical Holding Company INC. | $1,662.50 | 2023 | Bk3000, Bk3500 & Bk5000 Ultrasound System |
| Edap Technomed INC | $811.81 | 2022-2025 | |
| Histosonics, INC. | $533.06 | 2025 | |
| Blue Earth Diagnostics | $529.27 | 2024-2025 | Posluma |
| Angiodynamics, INC. | $422.21 | 2023-2025 | Nanoknife |
| I/O Urology Corp. | $157.79 | 2025 | Carepath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Frendl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.